The curative efficacy of auricular comprehensive therapy on menstrual migraine and its effect on serum prostaglandin.

التفاصيل البيبلوغرافية
العنوان:	The curative efficacy of auricular comprehensive therapy on menstrual migraine and its effect on serum prostaglandin.
عنوان ترانسليتريتد:	耳穴综合疗法治疗月经性偏头痛患者临床疗效及对血清前列腺素的影响.
المؤلفون:	Shao GL; School of Acupuncture-moxibustion and Tuina, Shandong University of Traditional Chinese Medicine, Jinan 250014, China., Huang SL; Department of Acupuncture and Moxibustion, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011., Li R; School of Acupuncture-moxibustion and Tuina, Shandong University of Traditional Chinese Medicine, Jinan 250014, China., Yang DH; Department of Acupuncture and Moxibustion, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011. jnyangdh@126.com., Wang MM; School of Acupuncture-moxibustion and Tuina, Shandong University of Traditional Chinese Medicine, Jinan 250014, China. 1144605744@qq.com.
المصدر:	Zhen ci yan jiu = Acupuncture research [Zhen Ci Yan Jiu] 2024 Feb 25; Vol. 49 (2), pp. 177-184.
نوع المنشور:	Randomized Controlled Trial; Journal Article
اللغة:	English; Chinese
بيانات الدورية:	Publisher: Institute Of Acupuncture And Moxibustion Country of Publication: China NLM ID: 8507710 Publication Model: Print Cited Medium: Print ISSN: 1000-0607 (Print) Linking ISSN: 10000607 NLM ISO Abbreviation: Zhen Ci Yan Jiu Subsets: MEDLINE
أسماء مطبوعة:	Publication: Beijing : Institute Of Acupuncture And Moxibustion Original Publication: Beijing, China : Published and distributed by World Books, [1980-
مواضيع طبية MeSH:	Prostaglandins* , Migraine Disorders*/drug therapy, Humans ; Female ; Flunarizine ; Dinoprostone ; Headache/therapy ; Syndrome
مستخلص:	Objectives: To observe the curative efficacy of auricular comprehensive therapy on menstrual migraine(MM) and its effect on serum prostaglandin F2α(PGF 2α ), prostaglandin E2(PGE 2 ) contents and ratio, so as to explore its possible mechanism. Methods: A total of 66 patients with MM of liver-fire syndrome were randomly divided into observation group (33 cases, 2 cases dropped off) and control group (33 cases, 2 cases dropped off), and 20 healthy women were included in the normal group. Patients in the control group were given flunarizine hydrochloride capsules orally, twice a day, for 3 consecutive weeks. Patients in the observation group were treated with auricular comprehensive therapy, starting 2-5 days before menstrual cramps, once a week, for a total of 3 weeks. The visual analogue scale (VAS) and migraine score were evaluated before and after treatment, and follow-up for 1 and 2 menstrual cycles. Serum PGF 2α and PGE 2 contents were measured before and after treatment, and the PGF 2α /PGE 2 ratio was calculated. The clinical effective rates in the two groups were calculated. Results: After treatment and follow-up for 1 and 2 menstrual cycles, the VAS scores, headache degree, the frequency and duration of headache attacks, as well as accompanying symptoms of the observation and control groups were lower than those before treatment( P <0.05), and those of the observation group was lower than those of the control group( P <0.05). Before treatment, the PGF 2α contents in the observation and control group were significantly higher( P <0.05), while the PGE 2 contents lower( P <0.05) and PGF 2α /PGE 2 ratio higher( P <0.05) than those in the normal group. After treatment, the serum PGF 2α contents in the observation and control group were significantly reduced compared with which before treatment( P <0.05), and were lower in the observation group than that in the control group ( P <0.05). The serum PGE 2 contents in the observation and control groups were significantly increased after treatment compared with which before treatment( P <0.05), with the contents in the observation group higher than that in the control group( P <0.05). The serum PGF 2α /PGE 2 ratio in the observation and control group was significantly reduced after treatment compared with which before treatment( P <0.05), with the control group higher than the normal group( P <0.05), and the observation group lower than the control group( P <0.05). The clinical effective rate of the observation group was 93.5% (29/31), and that of the control group was 77.4% (24/31). The effective rate of the observation group was significantly higher than that of the control group( P <0.05). Conclusions: The curative efficacy of auricular comprehensive therapy on MM with liver-fire syndrome is significantly better than that of oral flunarizine hydrochloride capsules, especially in relieving hea-daches, reducing the frequency and duration of headache attacks, as well as accompanying symptoms. Its mechanism may be related to regulating the abnormal PGF 2α and PGE 2 contents of patients and reducing the ratio of PGF 2α /PGE 2 .
References:	BURCH R. Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation： a narrative review ［J］. Headache ， 2020 ， 60 （ 1 ）： 200- 216. BHARADWAJ V N ， PORRECA F ， COWAN R P ， et al. A new hypothesis linking oxytocin to menstrual migraine ［J］. Headache ， 2021 ， 61 （ 7 ）： 1051- 1059. 罗文秀，赵佳玉，杨佳铭，等. 月经性偏头痛患者焦虑抑郁症状及睡眠质量［J］. 四川精神卫生， 2022 ， 35 （ 2 ）： 144- 148. STEWART W F ， LIPTON R B ， CHEE E ， et al. Menstrual cycle and headache in a population sample of migraineurs ［J］. Neurology ， 2000 ， 55 （ 10 ）： 1517- 1523. WANG Z W ， YIN Z H ， WANG X ， et al. Brain structural and functional changes during menstrual migraine： relationships with pain ［J］. Front Mol Neurosci ， 2022 ， 15 ： 967103. 刘璐，孙馥箐，赵洛鹏，等. 月经性偏头痛临床研究进展［J］. 中国疼痛医学杂志， 2018 ， 24 （ 9 ）： 679- 684. MAASUMI K ， TEPPER S J ， KRIEGLER J S. Menstrual migraine and treatment options： review ［J］. Headache ， 2017 ， 57 （ 2 ）： 194- 208. 杨佃会. 耳穴综合疗法对不同时期无先兆偏头痛患者血浆P物质的影响［J］. 中国针灸， 2009 ， 29 （ 3 ）： 189- 191. 仙晋，王玲，杨佃会. 耳穴综合疗法对偏头痛血瘀证患者血流变指标及血小板聚集率的影响［J］. 四川中医， 2015 ， 33 （ 7 ）： 166- 168. 王萌萌，于晓华，耿炜，等. 疏肝调神针法对偏头痛大鼠受体活性修饰蛋白1、5-羟色胺1D受体表达的影响［J］. 针刺研究， 2018 ， 43 （ 7 ）： 440- 444. 王萌萌，于晓华，耿炜，等. 疏肝调神针法对偏头痛大鼠行为学及血中相关神经肽、炎性物质表达的影响［J］. 针刺研究， 2018 ， 43 （ 6 ）： 375- 379. Headache Classification Committee of the International Headache Society（IHS）. The international classification of headache disorders， 3 ^rd edition （beta version）［J］. Cephalalgia ， 2013 ， 33 （ 9 ）： 629- 808. 国家中医药管理局. 中医病证诊断疗效标准（中华人民共和国中医药行业标准）［M］. 北京：中国中医药出版社， 2020 ： 237- 238. 王云凯，王富春. 中医妇科学［M］. 北京：中国中医药出版社， 2009 ： 135- 138. 郑筱萸. 中药新药临床研究指导原则：试行［M］. 北京：中国医药科技出版社， 2002 ： 108- 109. 刘赞华，赵永波. 月经性偏头痛的发病机制及防治［J］. 中国临床神经科学， 2010 ， 18 （ 3 ）： 329- 332. STEWART W F ， WOOD C ， REED M L ， et al. Cumulative lifetime migraine incidence in women and men ［J］. Cephalalgia ， 2008 ， 28 （ 11 ）： 1170- 1178. MARTIN V T ， LIPTON R B. Epidemiology and biology of menstrual migraine ［J］. Headache ， 2008 ， 48 （ s3 ）： S124- S130. 杨佳，沈燕，王舒. 经期偏头痛中医药临床研究进展［J］. 中华中医药杂志， 2013 ， 28 （ 8 ）： 2374- 2377. ROBBINS M S. Headache in pregnancy ［J］. Continuum Minneap Minn ， 2018 ， 24 （ 4 ）： 1092- 1107. PASCUAL J ， VILA C. Almotriptan： a review of 20 years’ clinical experience ［J］. Expert Rev Neurother ， 2019 ， 19 （ 8 ）： 759- 768. AKAISHI T ， TAKAYAMA S ， OHSAWA M ， et al. Successful treatment of intractable menstrual migraine with the traditional herbal medicine tokishakuyakusan ［J］. J Gen Fam Med ， 2019 ， 20 （ 3 ）： 118- 121. 邢爱群，陈垂海，吉晓天. 耳穴压豆联合氟桂利嗪治疗无先兆型偏头痛的临床观察［J］. 针刺研究， 2019 ， 44 （ 9 ）： 672- 676. 宫媛媛，聂波，张红，等. 耳穴神门压籽法对偏头痛病人大脑低频振荡振幅影响的研究［J］. 中西医结合心脑血管病杂志， 2018 ， 16 （ 3 ）： 276- 280. 林星辉. 耳穴贴压对原发性痛经患者前列腺素及β-内啡肽等的影响［D］. 长沙：湖南中医药大学， 2016. 喻建兵，彭勋超. 针刺风池穴治疗偏头痛的作用机理探讨［J］. 广西中医药大学学报， 2018 ， 21 （ 1 ）： 50- 52. 贺新泽，杨佃会. 耳穴综合疗法在偏头痛患者中的应用效果及对预后的影响研究［J］. 中医外治杂志， 2022 ， 31 （ 6 ）： 56- 58. HOLLAND S ， SILBERSTEIN S D ， FREITAG F ， et al. Evidence-based guideline update： NSAIDs and other complementary treatments for episodic migraine prevention in adults： report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society ［J］. Neurology ， 2012 ， 78 （ 17 ）： 1346- 1353. CHAUVEL V ， MULTON S ， SCHOENEN J. Estrogen-dependent effects of 5-hydroxytryptophan on cortical spreading depression in rat： modelling the serotonin-ovarian hormone interaction in migraine aura ［J］. Cephalalgia ， 2018 ， 38 （ 3 ）： 427- 436. DURHAM P L ， VAUSE C V ， DEROSIER F ， et al. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea ［J］. Headache ， 2010 ， 50 （ 5 ）： 844- 851. ANTONOVA M. Prostaglandins and prostaglandin receptor antagonism in migraine ［J］. Dan Med J ， 2013 ， 60 （ 5 ）： B4635. EDVINSSON L ， HAANES K A ， WARFVINGE K ， et al. CGRP as the target of new migraine therapies： successful translation from bench to clinic ［J］. Nat Rev Neurol ， 2018 ， 14 （ 6 ）： 338- 350. DO T P ， HOUGAARD A ， DUSSOR G ， et al. Migraine attacks are of peripheral origin： the debate goes on ［J］. J Headache Pain ， 2023 ， 24 （ 1 ）： 3. 廖柏丹，柳元娥，彭志谋，等. 艾灸神阙配合温针灸关元、三阴交治疗原发性痛经疗效观察［J］. 中国针灸， 2019 ， 39 （ 4 ）： 367- 370， 376.
فهرسة مساهمة:	Keywords: Auricular point comprehensive therapy; Menstrual migraine; Prostaglandin E2; Prostaglandin F2α Local Abstract: [Publisher, Chinese] 目的 : 观察耳穴综合疗法治疗月经性偏头痛（MM）的临床疗效及对血清前列腺素F2α（PGF 2α ）、前列腺素E2（PGE 2 ）含量、比值的影响，探讨其可能的作用机制。方法 : 将66例肝火旺盛型MM患者随机分为观察组（33例，脱落2例）和对照组（33例，脱落2例），并纳入20例健康女性作为正常组。对照组口服盐酸氟桂利嗪胶囊，每天2次，连续治疗3周；观察组予以耳穴综合疗法治疗，从月经来潮前2~5 d开始，1周治疗1次，共治疗3次。观察组与对照组分别于治疗前后及治疗后随访2个月经周期时以视觉模拟量尺（VAS）和偏头痛积分评价患者头痛程度，观察组、对照组和正常组分别于治疗前后测定月经期血清PGF 2α 、PGE 2 含量并计算PGF 2α /PGE 2 比值，评定两组MM患者的临床疗效。结果 : 与治疗前比较，观察组与对照组患者治疗后及随访时VAS评分均明显降低（ P <0.05），且观察组低于对照组（ P <0.05）。与治疗前比较，观察组与对照组患者治疗后及随访时偏头痛积分中头痛发作次数、每次发作持续时间、头痛程度及伴随症状评分均降低（ P <0.05），且观察组低于对照组（ P <0.05）。治疗前观察组与对照组患者PGF 2α 含量高于正常组（ P <0.05），PGE 2 含量低于正常组（ P <0.05），PGF 2α /PGE 2 比值高于正常组（ P <0.05）；与治疗前比较，观察组与对照组患者治疗后血清PGF 2α 含量明显降低（ P <0.05），且观察组低于对照组（ P <0.05）；与治疗前比较，观察组与对照组患者治疗后血清PGE 2 含量明显升高（ P <0.05），且观察组高于对照组（ P <0.05）；与治疗前比较，观察组与对照组患者治疗后血清PGF 2α /PGE 2 比值均明显降低（ P <0.05），且对照组较正常组明显升高（ P <0.05），观察组较对照组明显降低（ P <0.05）。观察组的临床有效率为93.5%（29/31），对照组的临床有效率为77.4%（24/31），观察组高于对照组（ P <0.05）。结论 : 耳穴综合疗法治疗肝火旺盛型MM疗效明显优于口服盐酸氟桂利嗪胶囊，在缓解头痛程度、减少头痛发作次数、发作时间以及伴随症状等方面疗效更好，其作用机制可能与调节患者异常PGF 2α 和PGE 2 含量，降低PGF 2α /PGE 2 比值有关。.
المشرفين على المادة:	0 (Prostaglandins) R7PLA2DM0J (Flunarizine) K7Q1JQR04M (Dinoprostone)
تواريخ الأحداث:	Date Created: 20240227 Date Completed: 20240229 Latest Revision: 20240229
رمز التحديث:	20240229
DOI:	10.13702/j.1000-0607.20221424
PMID:	38413039
قاعدة البيانات:	MEDLINE

الوصف
تدمد:	1000-0607
DOI:	10.13702/j.1000-0607.20221424